Toronto Dominion Bank lowered its position in shares of Danaher Co. (NYSE:DHR) by 0.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 468,533 shares of the conglomerate’s stock after selling 4,352 shares during the period. Toronto Dominion Bank’s holdings in Danaher were worth $66,944,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Next Capital Management LLC purchased a new position in Danaher during the 2nd quarter worth $31,000. Litman Gregory Asset Management LLC purchased a new stake in shares of Danaher in the second quarter valued at about $33,000. Altshuler Shaham Ltd boosted its stake in shares of Danaher by 59.3% during the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock worth $34,000 after buying an additional 89 shares during the period. Lenox Wealth Management Inc. acquired a new stake in shares of Danaher during the first quarter worth about $40,000. Finally, MRA Associates USA LLC purchased a new position in shares of Danaher during the second quarter worth about $40,000. 78.52% of the stock is owned by institutional investors and hedge funds.
In other news, SVP Angela S. Lalor sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $142.30, for a total transaction of $2,846,000.00. Following the sale, the senior vice president now owns 58,515 shares of the company’s stock, valued at approximately $8,326,684.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Robert S. Lutz sold 14,668 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $143.28, for a total value of $2,101,631.04. Following the sale, the chief accounting officer now directly owns 21,054 shares in the company, valued at approximately $3,016,617.12. The disclosure for this sale can be found here. Insiders have sold 177,202 shares of company stock worth $25,175,829 in the last ninety days. 11.40% of the stock is currently owned by corporate insiders.
DHR has been the topic of several recent research reports. Robert W. Baird boosted their price target on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Argus increased their price objective on Danaher to $165.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Wolfe Research began coverage on Danaher in a research note on Thursday, May 30th. They issued an “outperform” rating on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $155.00 target price (up from $142.00) on shares of Danaher in a research note on Friday, July 19th. Finally, Piper Jaffray Companies boosted their target price on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a report on Thursday, July 18th. Three equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Danaher currently has an average rating of “Buy” and an average price target of $143.54.
DHR traded up $2.99 during trading on Wednesday, reaching $139.58. The company’s stock had a trading volume of 117,856 shares, compared to its average volume of 1,809,357. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.91 and a current ratio of 2.32. The company’s fifty day moving average price is $140.24 and its 200-day moving average price is $134.97. Danaher Co. has a 52-week low of $94.59 and a 52-week high of $145.50. The company has a market capitalization of $99.97 billion, a price-to-earnings ratio of 30.90, a price-to-earnings-growth ratio of 2.52 and a beta of 0.94.
Danaher (NYSE:DHR) last issued its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.15 by $0.04. The business had revenue of $5.16 billion during the quarter, compared to the consensus estimate of $5.09 billion. Danaher had a return on equity of 11.53% and a net margin of 12.22%. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.15 EPS. Equities analysts predict that Danaher Co. will post 4.79 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%. Danaher’s dividend payout ratio is presently 15.04%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: What are Bollinger Bands?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.